The Golden Triangle Partnership, representing networking organisations in Cambridge, London and Oxford, has announced the signing of an agreement with BIOCOM.
France’s small biopharmaceutical and life science companies have been weakened by the financial crisis and had to face a drastic drop in investment in 2009.
The £3.5 billion a year currently spent on publicly-funded research generates an annual output of £45 billion in UK companies, according to a new report.